» Articles » PMID: 31991009

The Loss of Profilin 1 Causes Early Onset Paget's Disease of Bone

Overview
Date 2020 Jan 29
PMID 31991009
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Paget's disease of bone (PDB) is a late-onset disorder frequently caused by mutations in the SQSTM1 gene, leading to hyperactive osteoclasts and resulting in bone pain, deformities, and fractures. However, some more severe forms of PDB-negative for SQSTM1 mutations-have been described, in which the disease degenerates into bone cancers and shows a poor prognosis. Osteosarcoma is the most frequent and aggressive tumor arising in PDB (OS/PDB), with a 5-year survival rate almost nil, but the underlying molecular mechanism is unknown. Here, we investigated an extended pedigree with 11 individuals affected by early onset and polyostotic PDB, mainly interesting the appendicular skeleton. Interestingly, three members also developed secondary osteosarcoma. We performed exome sequencing and identified a 4-bp deletion in the PFN1 gene, resulting in the degradation of the mutant protein. Copy number screening on 218 PDB individuals of our biobank disclosed that four of them (~2%) carry a germline heterozygous deletion of PFN1. The identification of these subjects, who exhibit a particularly severe form of disease, emphasizes the diagnostic value of this genetic screening to identify PDB individuals predisposed to develop osteosarcoma. In fact, we detected allelic imbalance at PFN1 locus also in 8 of 14 (57%) sporadic OS/PDB, further proving its causative role. in vitro experiments also confirmed PFN1 involvement in this form of PDB. Indeed, CRISPR-Cas9-mediated Pfn1 knockout in pre-osteoclasts resulted into enhanced osteoclast differentiation and resorption, with the formation of large osteoclasts never described before in PDB. In addition, Pfn1 lacking pre-osteoblasts lost their differentiation capability and failed to efficiently mineralize bone. Moreover, they acquired features of malignant transformation, including loss of focal adhesions and increased invasion ability. In conclusion, these findings disclose PFN1 haploinsufficiency as the pathological mechanism in OS/PDB. © 2020 American Society for Bone and Mineral Research.

Citing Articles

Integrated transcriptomic analysis of human induced pluripotent stem cell-derived osteogenic differentiation reveals a regulatory role of KLF16.

Ru Y, Ma M, Zhou X, Kriti D, Cohen N, DSouza S bioRxiv. 2024; .

PMID: 38405902 PMC: 10888757. DOI: 10.1101/2024.02.11.579844.


Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget's Disease of Bone with Mutation Are Treatable by Alendronate.

Ling Z, Aini H, Kajikawa S, Shirakawa J, Tsuji K, Asou Y Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895866 PMC: 10610320. DOI: 10.3390/ph16101395.


Genetic Screening of ZNF687 and PFN1 in a Paget's Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687.

Huybrechts Y, De Ridder R, Steenackers E, Devogelaer J, Mortier G, Hendrickx G Calcif Tissue Int. 2023; 113(5):552-557.

PMID: 37728743 DOI: 10.1007/s00223-023-01137-5.


Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population.

Wu Y, Wu S, Yang E, Zhang G, Shi Q, Liang J Calcif Tissue Int. 2023; 113(2):207-215.

PMID: 37401976 DOI: 10.1007/s00223-023-01102-2.


A mutation in the ZNF687 gene that is responsible for the severe form of Paget's disease of bone causes severely altered bone remodeling and promotes hepatocellular carcinoma onset in a knock-in mouse model.

Russo S, Scotto di Carlo F, Maurizi A, Fortunato G, Teti A, Licastro D Bone Res. 2023; 11(1):16.

PMID: 36918542 PMC: 10014847. DOI: 10.1038/s41413-023-00250-3.